Evidence map›Paper›PMID 36443370›Full record

ArticleScientific reports2022

Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database.

Misaki Inoue, Kiyoka Matsumoto, Mizuki Tanaka, Yu Yoshida, Riko Satake, Fumiya Goto, Kazuyo Shimada, Ririka Mukai, Shiori Hasegawa, Takaaki Suzuki and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Misaki InoueLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Kiyoka MatsumotoLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Mizuki TanakaLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Yu YoshidaLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Riko SatakeLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Fumiya GotoLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Kazuyo ShimadaLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Ririka MukaiLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Shiori HasegawaLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Takaaki SuzukiLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan.
Hiroaki IkesueDepartment of Pharmacy, Kobe City Medical Center General Hospital, Kobe‑shi, Hyogo, Japan.
Jun LiaoDepartment of Pharmaceutical Informatics and Biological Statistics, School of Science, China Pharmaceutical University, Nanjing, China.
Tohru HashidaDepartment of Pharmacy, Kobe City Medical Center General Hospital, Kobe‑shi, Hyogo, Japan.
Mitsuhiro NakamuraLaboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu‑shi, Gifu, Japan. mnakamura@gifu-pu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36443370
PMCPMC9705710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.